Literature DB >> 26020613

Critical illness in pregnancy: part I: an approach to a pregnant patient in the ICU and common obstetric disorders.

Kalpalatha K Guntupalli1, Nicole Hall2, Dilip R Karnad3, Venkata Bandi4, Michael Belfort5.   

Abstract

Managing critically ill obstetric patients in the ICU is a challenge because of their altered physiology, different normal ranges for laboratory and clinical parameters in pregnancy, and potentially harmful effects of drugs and interventions on the fetus. About 200 to 700 women per 100,000 deliveries require ICU admission. A systematic five-step approach is recommended to enhance maternal and fetal outcomes: (1) differentiate between medical and obstetric disorders with similar manifestations, (2) identify and treat organ dysfunction, (3) assess maternal and fetal risk from continuing pregnancy and decide if delivery/termination of pregnancy will improve outcome, (4) choose an appropriate mode of delivery if necessary, and (5) optimize organ functions for safe delivery. A multidisciplinary team including the intensivist, obstetrician, maternal-fetal medicine specialist, anesthesiologist, neonatologist, nursing specialist, and transfusion medicine expert is key to optimize outcomes. Severe preeclampsia and its complications, HELLP (hemolysis, elevated liver enzymes, and low platelets) syndrome, and amniotic fluid embolism, which cause significant organ failure, are reviewed. Obstetric conditions that were not so common in the past are increasingly seen in the ICU. Thrombotic thrombocytopenic purpura of pregnancy is being diagnosed more frequently. Massive hemorrhage from adherent placenta is increasing because of the large number of pregnant women with scars from previous cesarean section. With more complex fetal surgical interventions being performed for congenital disorders, maternal complications are increasing. Ovarian hyperstimulation syndrome is also becoming common because of treatment of infertility with assisted reproduction techniques. Part II will deal with common medical disorders and their management in critically ill pregnant women.

Entities:  

Mesh:

Year:  2015        PMID: 26020613     DOI: 10.1378/chest.14-1998

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  8 in total

1.  Sleep Disturbances and Modulations in Inflammation: Implications for Pregnancy Health.

Authors:  Michele L Okun
Journal:  Soc Personal Psychol Compass       Date:  2019-04-11

Review 2.  Role of Critical Care Units in the management of obstetric patients (Review).

Authors:  Konstantinos Koukoubanis; Anastasia Prodromidou; Emmanouil Stamatakis; Dimitrios Valsamidis; Nikolaos Thomakos
Journal:  Biomed Rep       Date:  2021-05-06

3.  Placenta in the Critically Ill Mother.

Authors:  Dipali Anand Taggarsi; Bhuvana Krishna
Journal:  Indian J Crit Care Med       Date:  2021-12

4.  Preeclampsia and Related Problems.

Authors:  Amit M Narkhede; Dilip R Karnad
Journal:  Indian J Crit Care Med       Date:  2021-12

5.  Multidisciplinary team approach for an atypical presentation of postpartum thrombotic thrombocytopenic purpura and severe preeclampsia in the Intensive Care Unit.

Authors:  Jose R Navas-Blanco; Ileana Lopez-Plaza; Dragos M Galusca
Journal:  Saudi J Anaesth       Date:  2018 Oct-Dec

6.  Prediction of mechanical ventilation greater than 24 hours in critically ill obstetric patients: ten years of data from a tertiary teaching hospital in mainland China.

Authors:  Huiying Zhao; Guangjie Wang; Jie Lyu; Xiaohong Zhang; Youzhong An
Journal:  BMC Pregnancy Childbirth       Date:  2021-01-09       Impact factor: 3.007

7.  Development and validation of nomograms for predicting blood loss in placenta previa with placenta increta or percreta.

Authors:  Ruihui Lu; Ran Chu; Na Gao; Guiyang Li; Haiyang Tang; Xinxin Zhou; Xiangxin Lan; Shuyi Li; Xi Zhang; Yintao Xu; Yuyan Ma
Journal:  Ann Transl Med       Date:  2021-02

8.  Impact of violence against women on severe acute maternal morbidity in the intensive care unit, including neonatal outcomes: a case-control study protocol in a tertiary healthcare facility in Lima, Peru.

Authors:  Beatriz Paulina Ayala Quintanilla; Wendy E Pollock; Susan J McDonald; Angela J Taft
Journal:  BMJ Open       Date:  2018-03-14       Impact factor: 2.692

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.